| Abstract
Purpose: One of the most common malignancies peculiar to female health with few
symptoms, low response to therapy, difficult diagnosis, frequent relapse, and high
mortality, is ovarian cancer. Thus, our experiment, using Human amniotic fluid mes‑
enchymal stem cells (hAFMSCs) as a therapeutic tool, aims to find an efficient treat‑
ment approach for patients suffering from SKOV3 ovarian cancer.
Material & Methods: In this study, we obtained 5 ml amniotic fluid from
16–20 week pregnant women who underwent amniocentesis for routine prenatal
diagnosis by karyotyping in Al‐Zahra Hospital of Tabriz University of Medical
Sciences, Iran. Using trans wells in 24 wells plate, hAFMSCs were isolated from
all samples, co‐cultured with SKOV3 ovarian cancer cell line, and characterized
via flow cytometry and RT‐PCR. Human skin fibroblast cells (HSFCs) were iso‑
lated and used as a negative control. SKOV3 and HSFCs' viability after 5 days
was evaluated by MTT assay. Cell cycle and apoptotic genes were analyzed by
real‐time PCR.
Results: We successfully isolated and characterized hAFMSCs through it positiv‑
ity for CD44 and CD90 specific mesenchymal stem cell markers and negativity for
CD31 and CD45. Oct4 and NANOG were evaluated by RT‐PCR as pluripotency
markers, and visualized on 2% gel electrophoresis. We established hAFMS cell lines
after 5 days of co‐culturing the SKOV3 cells, viability was decreased; however,
HSFCs did not show toxicity by MTT assay. The genes indicated upregulation and
high expression by a real‐time PCR.
Conclusions: Our findings showed that hAFMSCs have natural tumor tropism, and
can release soluble factors in a cell culture, which cause an efficient anticancer effect.
Thus, we can use hAFMSCs for complete anticancer therapy on SKOV3 cell line at
cell culture condition and possibly in vivo in the near future. |